Andere Sprachen Alkermes plc

Aktien

A1JKVH

IE00B56GVS15

ALKS

Markt geschlossen - Nasdaq Andere Börsenplätze 22:00:00 25.04.2024			% 5 Tage	% 1. Jan.
24.44 ^USD	-0.85%		+2.86%	-11.90%

09.04.	Sektor-Update: Aktien des Gesundheitswesens steigen am Dienstag vor der Glocke	MT
09.04.	Alkermes: Potenzielles Narkolepsie-Medikament verbessert Wachsamkeit in Phase 1b-Studie	MT

Andere Sprachen

Erhalten Sie Zugang zu allen Nachrichten über alle Unternehmen: Verpassen Sie keine profitable Anlagechance mehr!

100% kostenlose Registrierung

Alkermes Announces Initiation of Vibrance-1 Phase 2 Study Evaluating ALKS 2680 for the Treatment of Narcolepsy Type 1	24.04.
Alkermes to Report First Quarter Financial Results on May 1, 2024	17.04.
Alkermes Announces Positive Topline Results from Phase 1b Study of ALKS 2680 Demonstrating Improved Wakefulness in Patients with Narcolepsy Type 2 and Idiopathic Hypersomnia	10.04.
BlackBerry, Alkermes rise; Neogen, Tilray Brands fall, Tuesday, 4/9/2024	09.04.
Sector Update: Health Care Stocks Edge Higher Pre-Bell Tuesday	09.04.
Alkermes Says Potential Narcolepsy Drug Improves Wakefulness in Phase 1b Study	09.04.
Alkermes plc Announces Positive Topline Results from Phase 1b Study of ALKS 2680 Demonstrating Improved Wakefulness in Patients with Narcolepsy Type 2 and Idiopathic Hypersomnia	09.04.
Alkermes Insider Sold Shares Worth $292,740, According to a Recent SEC Filing	19.03.
Alkermes Announces Appointment of Nancy S. Lurker to Board of Directors	07.03.
Alkermes Announces Appointment of Nancy S. Lurker to Board of Directors	07.03.
European Equities Traded in the US as American Depositary Receipts Advance Wednesday	06.03.
Alkermes Shares Down After Downgrade From UBS	20.02.
Sector Update: Health Care Stocks Higher Late Afternoon	15.02.
Sector Update: Health Care Stocks Higher Thursday Afternoon	15.02.
Alkermes Shares Rise After Q4 Results, Guidance	15.02.
Alkermes Q4 Non-GAAP Earnings, Revenue Increase; 2024 Outlook Issued -- Shares Gain Pre-Bell	15.02.
Alkermes: Q4 Earnings Snapshot	15.02.
Earnings Flash (ALKS) ALKERMES Posts Q4 Revenue $377.5M, vs. Street Est of $362.4M	15.02.
Alkermes plc announces an Equity Buyback for $400 million worth of its shares.	15.02.
Alkermes plc Reports Earnings Results for the Full Year Ended December 31, 2023	15.02.

Keine Ergebnisse zu dieser Suche

Alle Nachrichten Analystenempfehlungen Wichtige Fakten Insiders Transkripte Pressemitteilungen Offizielle Publikationen Andere Sprachen Trading-Ideen MarketScreener Artikel MarketScreener Analysen

Andere Sprachen Alkermes plc

Aktien

A1JKVH

IE00B56GVS15

ALKS

Andere Sprachen

Filter